7percent
Investor participating in BioOrbit's £9.8m seed round.
Last refreshed: 1 May 2026 · Appears in 1 active topic
What investment approach does 7percent Ventures use at seed stage?
Timeline for 7percent
Mentioned in: BioOrbit raises £9.8m for orbital pharma
UK Startups and Innovation- What does 7percent Ventures invest in?
- 7percent Ventures is a London-based seed investor focused on early-stage technology companies in Europe. It typically co-invests alongside larger seed funds, taking minority positions in B2B software, fintech and deep-tech startups.Source: 7percent public record
- Why does 7percent take smaller stakes than other VCs?
- The fund's philosophy is to preserve founder ownership while taking a position large enough to drive meaningful returns. It prioritises being in the syndicate at seed rather than leading rounds.Source: 7percent public record
- What is 7percent Ventures and where is it based?
- 7percent Ventures is a London-based early-stage venture capital investor focused on pre-seed and seed rounds in European technology startups. Its name reflects its philosophy of taking a meaningful but non-controlling stake in very early-stage companies, preserving founder ownership. It typically backs B2B software, fintech and deep-tech founders as a participant investor in syndicates.Source: event
- What kind of companies does 7percent Ventures back?
- 7percent Ventures focuses on technology-led founders in Europe, with a portfolio concentrated in B2B software, fintech and increasingly deep tech. It operates primarily as a participant investor rather than a deal lead, co-investing alongside established seed funds and accelerators.Source: event
- Did 7percent Ventures invest in BioOrbit?
- Yes. 7percent participated in BioOrbit's £9.8m seed round in April 2026, the world's largest seed for in-space drug manufacturing. The syndicate was co-led by LocalGlobe and Breega, with Auxxo, Seedcamp and Type One also participating.Source: event
- How does 7percent Ventures differ from a typical VC firm?
- Unlike most VCs that lead rounds and take board seats, 7percent Ventures writes smaller cheques as a participant investor in syndicates led by others. This approach lets the fund back more companies at very early stages without requiring control or board representation, while still securing a stake large enough to matter if portfolio companies succeed.
Background
7percent Ventures is a London-based early-stage venture capital investor that focuses on pre-seed and seed rounds, writing smaller cheques and participating alongside larger co-investors in high-conviction syndicates. The fund's name reflects its philosophy of taking a meaningful but non-controlling position in very early-stage companies, preserving founder ownership while securing a stake large enough to drive meaningful returns. It primarily backs technology-led founders in Europe.
7percent typically operates as a participant investor rather than a deal lead, co-investing with established seed funds and accelerators. Its portfolio is concentrated in B2B software, fintech and increasingly deep tech as the European seed landscape has shifted toward science-led ventures.
7percent participated in BioOrbit's £9.8m in-space drug manufacturing seed in April 2026 as part of the syndicate alongside LocalGlobe, Breega, Auxxo, Seedcamp and Type One. The round is the world's largest seed for in-space manufacturing, enabled by a joint UK regulatory pathway published by four government bodies in March 2026.